Detailed Information

Cited 0 time in webofscience Cited 14 time in scopus
Metadata Downloads

Frequent rhabdomyolysis in anti-NMDA receptor encephalitis

Full metadata record
DC Field Value Language
dc.contributor.authorLim, Jung-Ah-
dc.contributor.authorLee, Soon-Tae-
dc.contributor.authorKim, Tae-Joon-
dc.contributor.authorMoon, Jangsup-
dc.contributor.authorSunwoo, Jun-Sang-
dc.contributor.authorByun, Jung-Ick-
dc.contributor.authorJung, Keun-Hwa-
dc.contributor.authorJung, Ki-Young-
dc.contributor.authorChu, Kon-
dc.contributor.authorLee, Sang Kun-
dc.date.accessioned2021-08-11T16:46:49Z-
dc.date.available2021-08-11T16:46:49Z-
dc.date.issued2016-09-15-
dc.identifier.issn0165-5728-
dc.identifier.issn1872-8421-
dc.identifier.urihttps://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8759-
dc.description.abstractThe aim of this study was to analyze the clinical presentation and provocation factors of rhabdomyolysis in anti-NMDAR encephalitis. Among the 16 patients with anti-NMDAR encephalitis in our institutional cohort, nine patients had elevated CK enzyme levels and clinical evidence of rhabdomyolysis. Rhabdomyolysis was more frequent after immunotherapy. The use of dopamine receptor blocker (DRB) increased the risk of rhabdomyolysis. None of the patients without rhabdomyolysis received DRBs. Rhabdomyolysis is a frequent complication in anti-NMDAR encephalitis and more common after immunotherapy and the use of DRBs increases the risk. Therefore, DRBs should be administered carefully in patients with anti-NMDAR encephalitis. (C) 2016 Elsevier B.V. All rights reserved.-
dc.format.extent3-
dc.language영어-
dc.language.isoENG-
dc.publisherElsevier BV-
dc.titleFrequent rhabdomyolysis in anti-NMDA receptor encephalitis-
dc.typeArticle-
dc.publisher.location네델란드-
dc.identifier.doi10.1016/j.jneuroim.2016.08.002-
dc.identifier.scopusid2-s2.0-84981313830-
dc.identifier.wosid000383936600026-
dc.identifier.bibliographicCitationJournal of Neuroimmunology, v.298, pp 178 - 180-
dc.citation.titleJournal of Neuroimmunology-
dc.citation.volume298-
dc.citation.startPage178-
dc.citation.endPage180-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasssci-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaImmunology-
dc.relation.journalResearchAreaNeurosciences & Neurology-
dc.relation.journalWebOfScienceCategoryImmunology-
dc.relation.journalWebOfScienceCategoryNeurosciences-
dc.subject.keywordPlusMETHYL-D-ASPARTATE-
dc.subject.keywordPlusDIAGNOSIS-
dc.subject.keywordPlusRISK-
dc.subject.keywordAuthorEncephalitis-
dc.subject.keywordAuthorNMDA-
dc.subject.keywordAuthorAutoimmune encephalitis-
dc.subject.keywordAuthorRhabdomyolysis-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Neurology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE